Deferred Tax Assets, Gross of TuHURA Biosciences, Inc./NV from 31 Dec 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
TuHURA Biosciences, Inc./NV quarterly Deferred Tax Assets, Gross in USD history and change rate from 31 Dec 2012 to 31 Dec 2024.
  • TuHURA Biosciences, Inc./NV Deferred Tax Assets, Gross for the quarter ending 31 Dec 2024 was $46,546,057, a 118% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Change (%)

TuHURA Biosciences, Inc./NV Quarterly Deferred Tax Assets, Gross (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $46,546,057 +$25,179,139 +118% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q2 2024 $31,345,000 -$1,024,000 -3.2% 30 Jun 2024 10-K 07 Oct 2024 2024 FY
Q4 2023 $21,366,918 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q2 2023 $32,369,000 +$4,385,000 +16% 30 Jun 2023 10-K 07 Oct 2024 2024 FY
Q2 2022 $27,984,000 +$6,021,000 +27% 30 Jun 2022 10-K 18 Sep 2023 2023 FY
Q2 2021 $21,963,000 +$8,803,000 +67% 30 Jun 2021 10-K 27 Sep 2022 2022 FY
Q2 2020 $13,160,000 +$1,381,399 +12% 30 Jun 2020 10-K 28 Sep 2021 2021 FY
Q2 2019 $11,778,601 +$1,649,178 +16% 30 Jun 2019 10-K 18 Sep 2020 2020 FY
Q2 2018 $10,129,423 +$2,149,578 +27% 30 Jun 2018 10-K 09 Sep 2019 2019 FY
Q2 2017 $7,979,845 +$2,740,805 +52% 30 Jun 2017 8-K 03 Jun 2019
Q2 2016 $5,239,040 +$701,877 +15% 30 Jun 2016 10-K 27 Sep 2017 2017 FY
Q2 2015 $4,537,163 +$1,698,661 +60% 30 Jun 2015 10-K 13 Sep 2016 2016 FY
Q2 2014 $2,838,502 30 Jun 2014 10-K 16 Nov 2015 2015 FY
Q4 2013 $1,947,946 +$1,608,541 +474% 31 Dec 2013 10-K 28 Aug 2014 2014 FY
Q4 2012 $339,405 31 Dec 2012 10-K 28 Aug 2014 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.